Stream 5 Session #6: Free communications - Diabetes complications- Discovery Science
Tracks
Meeting Room 103
| Thursday, August 20, 2026 |
| 2:00 PM - 3:30 PM |
| Meeting Room 103 (Level 1) |
Speaker
Dr Jay Jha
Senior Research Fellow
Monash University
Nox5 deficiency mitigates renal injury in a rabbit model of metabolic syndrome through modulation of oxidative stress, ER stress and ferroptosis
2:00 PM - 2:15 PMBiography
Dr. Jha, Senior Research Fellow at Monash’s School of Translational Medicine, leads research on therapeutic targets and biomarkers for diabetes, kidney disease, and cardiorenal-syndrome. A Monash PhD graduate, he has held prestigious fellowships (JDRF, NHMRC) and continues to drive translational advances to improve health outcomes in diabetes and renal disease.
Dr Habib Francis
Postodoctoral Research Fellow
University of Sydney
Comparison of mRNA and proteins in complications of type 2 diabetes: Integrating proteomics with transcriptomics
2:15 PM - 2:30 PMBiography
Dr. Francis is a molecular biologist and clinical researcher at the NHMRC Clinical Trials Centre at the University of Sydney. His work integrates proteomic, transcriptomic, and genetic analyses to identify molecular biomarkers associated with vascular complications in Type 2 diabetes and uncover mechanistic links between metabolic dysfunction and vascular injury.
Dr Qiming Gong
China
The Affiliated Hospital of Southwest Medical University
Itaconate inhibits macrophage-mediated trained immunity to improve diabetic kidney disease
2:30 PM - 2:45 PMBiography
Dr. Qiming Gong is a researcher at the Affiliated Hospital of Southwest Medical University. Specializing in macrophage mechanisms in diabetic kidney disease, he has published over 20 SCI papers with 100+ citations, contributing significantly to understanding immune-metabolic pathways in diabetes.
Dr Huang Yating
Doctoral Candidate
Beijing Hospital / Fifth School of Clinical Medicine / Peking University
Activated oligoadenylate synthetase-ribonuclease L pathway promotes endothelial pyroptosis and impairs diabetic wound healing via thioredoxin-interacting protein m6A methylation
2:45 PM - 3:00 PMBiography
Dr. Yating Huang is a Ph.D. candidate at the Department of Endocrinology, Beijing Hospital, Peking University. Her research focuses on the molecular mechanisms of diabetic wound healing. With multiple first-author publications in Q1 journals and a cumulative impact factor exceeding 36, her research focuses on molecular mechanisms underlying metabolic complications.
Ms Minling Huang
PhD student
Department of Diabetes
Mechanistic study on the pathogenic role of cell division autoantigen 1 in diabetic kidney disease
3:00 PM - 3:15 PMBiography
Minling Huang is a PhD candidate in Translation Medicine at Monash University, Australia. Her research focuses on identifying therapeutic targets for diabetic kidney disease, with particular emphasis on the role of cell division autoantigen 1 (CDA1) in disease progression using mouse models and transcriptomic approaches.
Dr Amelia Fotheringham
Research Officer
Mater Research Institute / University of Queensland
Systemic immune profiling in a CD-1 mouse model of diabetes complications following RAGE antagonism therapy.
3:15 PM - 3:30 PMBiography
Dr Fotheringham is a passionate Early Career Researcher dedicated to furthering understanding of diabetes and its chronic complications and developing meaningful therapeutic targets. She is particularly interested in the understanding the interactions between metabolism, the kidney and the immune system that occur with diabetes and diabetic kidney disease.
